Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmaceutical applications compression effects

The primary use for dibasic calcium phosphate in pharmaceutical applications is as a tablet or capsule diluent. It is also used as an excipient for direct compression formulations of hard tablets requiring a good disintegrant and an effective lubricant. It has limited use as a mineral supplement for calcium replenishment. Diluents often comprise the bulk of the tablet formulation, with use levels between 40 to 90 % of the tablet weight. It has also foimd use as an adsorbent and as a thickening agent in creams and ointments. The pharmacopeial specifications for Dibasic Calcimn Phosphate USP are as follows ... [Pg.425]

Lack of biocompatibility [39] was mentioned but seems to be now reconsidered there is few applications in biomedical domain. The main applications are in food [40] as a thickener or stabilizer of emulsions. They are also used in personnal care, cosmetic and pharmaceutic compositions and household care products for which there are many patents [37, 41,42]. Low molecular weight sulphated derivatives of galactomannan have anticoagulant activity[28]. Different pharmaceutical applications are mentioned in the literature as example for blood glucose-lowering effect[43], or to produce tablets by compression and control the release of drugs [44-46]... [Pg.1149]


See other pages where Pharmaceutical applications compression effects is mentioned: [Pg.270]    [Pg.394]    [Pg.552]    [Pg.18]    [Pg.530]    [Pg.915]    [Pg.429]    [Pg.491]    [Pg.415]   
See also in sourсe #XX -- [ Pg.66 , Pg.67 , Pg.68 ]




SEARCH



Compressibility effect

Compressive effects

Pharmaceutical applications

Pharmaceutical effects

© 2024 chempedia.info